663 related articles for article (PubMed ID: 18361899)
1. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
[TBL] [Abstract][Full Text] [Related]
2. Relationship between B-type natriuretic peptide levels and ventilatory response during cardiopulmonary exercise test in patients with chronic heart failure.
Scardovi AB; Coletta C; Aspromonte N; Perna S; Infusino T; Carunchio A; D'Errigo P; Seccareccia F; De Maria R; Greggi M; Di Giacomo T; Ricci R; Ceci V
Minerva Cardioangiol; 2005 Aug; 53(4):313-20. PubMed ID: 16177675
[TBL] [Abstract][Full Text] [Related]
3. Brain natriuretic peptide is a reliable indicator of ventilatory abnormalities during cardiopulmonary exercise test in heart failure patients.
Scardovi AB; De Maria R; Colettat C; Aspromonte N; Perna S; Infusino T; D'Errigo P; Rosato S; Greggi M; Di Giacomo T; Riccio R; Cec V
Med Sci Monit; 2006 May; 12(5):CR191-5. PubMed ID: 16641874
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric risk stratification in patients with mild to moderate chronic heart failure.
Scardovi AB; De Maria R; Coletta C; Aspromonte N; Perna S; Cacciatore G; Parolini M; Ricci R; Ceci V
J Card Fail; 2007 Aug; 13(6):445-51. PubMed ID: 17675058
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L
Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960
[TBL] [Abstract][Full Text] [Related]
6. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
[TBL] [Abstract][Full Text] [Related]
8. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.
Price JF; Thomas AK; Grenier M; Eidem BW; O'Brian Smith E; Denfield SW; Towbin JA; Dreyer WJ
Circulation; 2006 Sep; 114(10):1063-9. PubMed ID: 16940194
[TBL] [Abstract][Full Text] [Related]
9. Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value.
Guazzi M; Arena R; Ascione A; Piepoli M; Guazzi MD;
Am Heart J; 2007 May; 153(5):859-67. PubMed ID: 17452165
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Hoes AW; van Veldhuisen DJ
Am Heart J; 2006 May; 151(5):1012.e1-5. PubMed ID: 16644323
[TBL] [Abstract][Full Text] [Related]
14. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope.
Toste A; Soares R; Feliciano J; Andreozzi V; Silva S; Abreu A; Ramos R; Santos N; Ferreira L; Ferreira RC
Rev Port Cardiol; 2011 Oct; 30(10):781-7. PubMed ID: 22118129
[TBL] [Abstract][Full Text] [Related]
16. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.
de Groote P; Dagorn J; Soudan B; Lamblin N; McFadden E; Bauters C
J Am Coll Cardiol; 2004 May; 43(9):1584-9. PubMed ID: 15120815
[TBL] [Abstract][Full Text] [Related]
18. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide levels in obese patients with advanced heart failure.
Horwich TB; Hamilton MA; Fonarow GC
J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of ventilatory efficiency with beta-blocker therapy in heart failure.
Arena RA; Guazzi M; Myers J; Abella J
Med Sci Sports Exerc; 2007 Feb; 39(2):213-9. PubMed ID: 17277583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
